Reconsidering the evaluation of addiction treatment: from retrospective follow‐up to concurrent recovery monitoring

Addiction - Tập 100 Số 4 - Trang 447-458 - 2005
A. Thomas McLellan1,2, James R. McKay1,2, Robert Forman1,2, John S. Cacciola1,2, Jack Kemp3
1Department of Psychiatry, University of Pennsylvania
2Treatment Research Institute
3Delaware Department of Substance Abuse and Mental Health, Delaware, USA

Tóm tắt

ABSTRACTHistorically, addiction treatments have been delivered and evaluated under an acute‐care format. Fixed amounts or durations of treatment have been provided and their effects evaluated 6–12 months after completion of care. The explicit expectation of treatment has been enduring reductions in substance use, improved personal health and social function, generally referred to as ‘recovery’. In contrast, treatments for chronic illnesses such as diabetes, hypertension and asthma have been provided for indeterminate periods and their effects evaluated during the course of those treatments. Here the expectations are for most of the same results, but only during the course of continuing care and monitoring. The many similarities between addiction and mainstream chronic illnesses stand in contrast to the differences in the ways addiction is conceptualized, treated and evaluated. This paper builds upon established methods of during‐treatment evaluation developed for the treatment of other chronic illnesses and suggests a parallel evaluation system for out‐patient, continuing‐care forms of addiction treatment. The suggested system retains traditional patient‐level, behavioral outcome measures of recovery, but suggests that these outcomes should be collected and reported immediately and regularly by clinicians at the beginning of addiction treatment sessions, as a way of evaluating recovery progress and making decisions about continuing care. We refer to this paradigm as ‘concurrent recovery monitoring’ and discuss its potential for producing more timely, efficient, clinically relevant and accountable evaluations.

Từ khóa


Tài liệu tham khảo

10.1037/0893-164X.11.4.308

Armor D. J., 1976, Alcoholism and Treatment

10.1007/978-1-4613-9089-3

10.1037/0022-006X.69.2.197

10.1001/jama.288.14.1775

10.1023/B:PREV.0000037641.26017.00

Deming W. E., 1952, Elementary Principles of the Statistical Control of Quality.

10.1016/S0149-7189(03)00037-5

10.15288/jsa.1975.36.88

10.1046/j.1360-0443.1996.911217733.x

Food and Drug Administration (FDA, 1980, Compliance Policy Guidelines

Fox A., 2000, Open Minds Yearbook of Managed Behavioral Healthmarket Share in the United States, 2000–2001

Garnick D. W., 2002, Establishing the feasibility of performance measures for alcohol and other drugs, Journal of Substance Abuse Treatment, 45, 124

Gerstein D., 1990, Treating Drug Problems

10.1016/S0740-5472(02)00230-1

10.1016/S0376-8716(00)00211-8

10.1016/S0740-5472(03)00128-4

Horgan C., 2001, Recent Developments in Alcoholism, 25

10.1037/0003-066X.51.10.1059

10.1016/S0740-5472(97)00016-0

10.1177/0193841X9802200404

Hubbard R. L., 1989, Drug Abuse Treatment: a National Study of Effectiveness

10.1046/j.1360-0443.2002.00004.x

10.1002/1097-4679(197110)27:4<455::AID-JCLP2270270412>3.0.CO;2-R

Institute of Medicine, 1998, Bridging the Gap Between Practice and Research: Forging Partnerships with Community‐Based Drug and Alcohol Treatment

Joint Commission on Accreditation of Health‐care Organization (JCAHO) (2002)Attributes of Core Performance Measures and Associated Evaluation Criteria.Available at:http://www.jcaho.org/pms/core+measures/attributesof+core+performance+measures.htm.

10.1111/j.1468-2850.1996.tb00068.x

10.1037/0022-006X.69.2.159

10.1016/S0025-7125(05)70551-4

10.1093/her/11.2.243

McGlynn E. A., 1998, Choosing and evaluating clinical performance measures, Joint Commission Journal on Quality Improvement, 24, 470

10.1037/0022-006X.65.5.778

10.1037/0022-006X.67.3.420

10.1037/0022-006X.72.6.967

10.1046/j.1360-0443.2001.9622134.x

10.1377/hlthaff.17.5.147

McLellan A. T., 2002, Drug Abuse Treatment Through Collaboration: Practice and Research Partnerships That Work, 119

10.1001/jama.1993.03500150065028

10.1016/S0740-5472(03)00156-9

McLellan A. T., 1995, Outcomes Assessment in Clinical Practice, 16

10.1016/0740-5472(93)90071-9

10.1001/archpsyc.1983.04390010030004

McLellan A. T., 1998, Principles of Addiction Medicine, 24

10.1001/jama.284.13.1689

10.1007/978-1-4899-3591-5_6

MEDSTAT Group, 2001, Medicare, Medicaid, and Managed Care Analysis Project: Round Two Analytic Tables

10.1016/S0005-7894(83)80107-5

10.1007/978-1-4613-2191-0

Moos R. H., 1990, Alcoholism Treatment: Context, Process and Outcome

10.1111/1467-9868.00389

Musto D. F., 1973, The American Disease: the Origins of Narcotic Control

National Committee on Quality Assurance.(2004)HEDIS Measures. Available at:http://www.ncqa.org/Programs/HEDIS.

National Institute on Drug Abuse (NIDA, 1999, Principles of Drug Addiction Treatment: a Research‐Based Guide

10.1016/S0140-6736(96)90409-2

10.1037/0022-006X.59.3.439

Osher F. C., 1989, Treatment of patients with psychiatric and psychoactive substance abuse disorders, Hospital and Community Psychiatry, 40, 1025

10.15288/jsa.1998.59.513

10.15288/jsa.1997.58.7

10.1111/j.1360-0443.1993.tb02123.x

Scott C., 2004, Ethical issues in the conduct of longitudinal studies of addiction treatment, Journal of Substance Abuse Treatment, 27, 254

10.1016/j.jsat.2004.06.001

10.1001/archpsyc.59.6.538

10.1037/0893-164X.11.4.294

10.1016/0306-4603(96)00039-1

Stewart R. G., 1989, The Medical Outcomes Study.

10.1016/S0306-4603(98)00029-X

Substance Abuse and Mental Health Services Administration (SAMHSA) Office of Applied Studies, 2002, National Survey of Substance Abuse Treatment Services (N‐SSATS): 2000 Data on Substance Abuse Treatment Facilities

Substance Abuse and Mental Health Services Administration (SAMHSA, 1997, 1997 Uniform Facility Data Set (UFDS)—Data on Substance Abuse Treatment Facilities

Substance Abuse and Mental Health Services Administration (SAMHSA)  (2002b)  Report  to  Congress  on  the  prevention and treatment of co‐occurring substance abuse disorders and mental disorders. Washington DC:Substance Abuse and Mental Health Services Administration.Available at:http://alt.samhsa.gov/reports/congress2002/.

10.1002/(SICI)1097-0258(20000430)19:8<1011::AID-SIM414>3.0.CO;2-M

10.1037/0893-164X.13.4.259

10.2307/3350391

White W., 1998, Slaying the Dragon: the History of Addiction Treatment and Recovery in America

Winick C., 1962, Maturing out of narcotic addiction, Bulletin on Narcotics, 14, 1

Thông tin
Thông tin xuất bản

Addiction

Tập 100 Số 4

447-458

Thông tin tác giả